NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
(NYSE MKT:NRXS), CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced new medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), representing approximately 566,000 total covered lives, in […]